Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer
NCT00159458Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Jul 2003
- Primary completion
- Nov 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in breast cancer, sponsored by University of Southern California. Started Jul 2003; status: terminated.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00159458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159458.